{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:44:45Z","timestamp":1793083485057,"version":"4.5.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>There is still unmet demand for effective, safe, and patient-friendly anti-thrombotics to treat deep vein thrombosis (DVT) during pregnancy. Here we first engineer a bioactive amphiphile (TLH) by simultaneously conjugating Tempol and linoleic acid onto low molecular weight heparin (LMWH), which can assemble into multifunctional nanoparticles (TLH NP). In pregnant rats with DVT, TLH NP can target and dissolve thrombi, recanalize vessel occlusion, and eradicate the recurrence of thromboembolism, thereby reversing DVT-mediated intrauterine growth restriction and delayed development of fetuses. Mechanistically, therapeutic effects of TLH NP are realized by inhibiting platelet aggregation, facilitating thrombolysis, reducing local inflammation, attenuating oxidative stress, promoting endothelial repair, and increasing bioavailability. By decorating with a fibrin-binding peptide, targeting efficiency and therapeutic benefits of TLH NP are considerably improved. Importantly, LMWH nanotherapies show no toxicities to the mother and fetus at the dose 10-time higher than the examined therapeutic dosage.<\/jats:p>","DOI":"10.1038\/s41467-022-34878-2","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T05:17:34Z","timestamp":1669180654000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Functionally integrating nanoparticles alleviate deep vein thrombosis in pregnancy and rescue intrauterine growth restriction"],"prefix":"10.1038","volume":"13","author":[{"given":"Juan","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanfang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4911-7942","authenticated-orcid":false,"given":"Hongbo","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0984-2947","authenticated-orcid":false,"given":"Jianxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,22]]},"reference":[{"key":"34878_CR1","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nrcardio.2015.83","volume":"12","author":"JA Heit","year":"2015","unstructured":"Heit, J. A. Epidemiology of venous thromboembolism. Nat. Rev. Cardiol. 12, 464\u2013474 (2015).","journal-title":"Nat. Rev. Cardiol."},{"key":"34878_CR2","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1056\/NEJMcp1407434","volume":"373","author":"IA Greer","year":"2015","unstructured":"Greer, I. A. Pregnancy complicated by venous thrombosis. N. Engl. J. Med. 373, 540\u2013547 (2015).","journal-title":"N. Engl. J. Med."},{"key":"34878_CR3","doi-asserted-by":"publisher","first-page":"S309","DOI":"10.21037\/cdt.2017.10.08","volume":"7","author":"P Devis","year":"2017","unstructured":"Devis, P. & Knuttinen, M. G. Deep venous thrombosis in pregnancy: incidence, pathogenesis and endovascular management. Cardiovasc. Diagn. Ther. 7, S309\u2013S319 (2017).","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"34878_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3109\/14767058.2014.913130","volume":"28","author":"K Meng","year":"2015","unstructured":"Meng, K., Hu, X., Peng, X. & Zhang, Z. Incidence of venous thromboembolism during pregnancy and the puerperium: a systematic review and meta-analysis. J. Matern. Fetal Neonatal Med. 28, 245\u2013253 (2015).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"34878_CR5","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1053\/beog.2001.0202","volume":"15","author":"IA Greer","year":"2001","unstructured":"Greer, I. A. & Thomson, A. J. Management of venous thromboembolism in pregnancy. Best. Pract. Res. Clin. Obstet. Gynaecol. 15, 583\u2013603 (2001).","journal-title":"Best. Pract. Res. Clin. Obstet. Gynaecol."},{"key":"34878_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1159\/000299596","volume":"12","author":"M Hellgren","year":"1981","unstructured":"Hellgren, M. & Blomback, M. Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium. Gynecol. Obstet. Invest. 12, 141\u2013154 (1981).","journal-title":"Gynecol. Obstet. Invest."},{"key":"34878_CR7","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1042\/BST0330428","volume":"33","author":"VA Holmes","year":"2005","unstructured":"Holmes, V. A. & Wallace, J. M. Haemostasis in normal pregnancy: a balancing act? Biochem. Soc. Trans. 33, 428\u2013432 (2005).","journal-title":"Biochem. Soc. Trans."},{"key":"34878_CR8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.thromres.2004.08.004","volume":"114","author":"B Brenner","year":"2004","unstructured":"Brenner, B. Haemostatic changes in pregnancy. Thromb. Res. 114, 409\u2013414 (2004).","journal-title":"Thromb. Res."},{"key":"34878_CR9","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1056\/NEJMra0707993","volume":"359","author":"PE Marik","year":"2008","unstructured":"Marik, P. E. & Plante, L. A. Venous thromboembolic disease and pregnancy. N. Engl. J. Med. 359, 2025\u20132033 (2008).","journal-title":"N. Engl. J. Med."},{"key":"34878_CR10","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.it.2018.04.010","volume":"39","author":"I Budnik","year":"2018","unstructured":"Budnik, I. & Brill, A. Immune factors in deep vein thrombosis initiation. Trends Immunol. 39, 610\u2013623 (2018).","journal-title":"Trends Immunol."},{"key":"34878_CR11","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1161\/01.CIR.0000014611.28864.1E","volume":"105","author":"Herkert","year":"2002","unstructured":"Herkert & Nadph, O. oxidase mediates tissue factor-dependent surface procoagulant activity by thrombin in human vascular smooth muscle cells. Circulation 105, 2030 (2002).","journal-title":"Circulation"},{"key":"34878_CR12","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1084\/jem.20112322","volume":"209","author":"ML von Br\u00fchl","year":"2012","unstructured":"von Br\u00fchl, M. L. et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J. Exp. Med. 209, 819\u2013835 (2012).","journal-title":"J. Exp. Med."},{"key":"34878_CR13","first-page":"54","volume":"24","author":"N Ibeh","year":"2015","unstructured":"Ibeh, N. et al. Normal pregnancy and coagulation profile: from the first through the third trimester. Niger. J. Med. 24, 54\u201357 (2015).","journal-title":"Niger. J. Med."},{"key":"34878_CR14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1746-1596-5-24","volume":"5","author":"F Barut","year":"2010","unstructured":"Barut, F. et al. Intrauterine growth restriction and placental angiogenesis. Diagn. Pathol. 5, 24 (2010).","journal-title":"Diagn. Pathol."},{"key":"34878_CR15","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S0301-2115(00)00491-7","volume":"95","author":"LL Peeters","year":"2001","unstructured":"Peeters, L. L. Thrombophilia and fetal growth restriction. Eur. J. Obstet. Gynecol. Reprod. Biol. 95, 202\u2013205 (2001).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"34878_CR16","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.jvir.2015.11.024","volume":"27","author":"SA Harris","year":"2016","unstructured":"Harris, S. A., Velineni, R. & Davies, A. H. Inferior vena cava filters in pregnancy: a systematic review. J. Vasc. Interv. Radiol. 27, 354\u2013360 (2016).","journal-title":"J. Vasc. Interv. Radiol."},{"key":"34878_CR17","doi-asserted-by":"publisher","first-page":"j2344","DOI":"10.1136\/bmj.j2344","volume":"357","author":"F Khan","year":"2017","unstructured":"Khan, F., Vaillancourt, C. & Bourjeily, G. Diagnosis and management of deep vein thrombosis in pregnancy. Br. Med. J. 357, j2344 (2017).","journal-title":"Br. Med. J."},{"key":"34878_CR18","doi-asserted-by":"publisher","first-page":"95.e91","DOI":"10.1016\/j.ajog.2020.07.023","volume":"224","author":"R Hastie","year":"2021","unstructured":"Hastie, R. et al. Aspirin use during pregnancy and the risk of bleeding complications: a Swedish population-based cohort study. Am. J. Obstet. Gynecol. 224, 95.e91\u201395.e12 (2021).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"34878_CR19","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1056\/NEJM198508083130603","volume":"313","author":"S Zierler","year":"1985","unstructured":"Zierler, S. & Rothman, K. J. Congenital heart disease in relation to maternal use of bendectin and other drugs in early pregnancy. N. Engl. J. Med. 313, 347\u2013352 (1985).","journal-title":"N. Engl. J. Med."},{"key":"34878_CR20","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1182\/bloodadvances.2018024786","volume":"2","author":"P Monagle","year":"2018","unstructured":"Monagle, P. et al. American society of hematology 2018 guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism. Blood Adv. 2, 3292\u20133316 (2018).","journal-title":"Blood Adv."},{"key":"34878_CR21","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/bjh.13209","volume":"168","author":"L Duffett","year":"2015","unstructured":"Duffett, L. & Rodger, M. LMWH to prevent placenta-mediated pregnancy complications: an update. Br. J. Haematol. 168, 619\u2013638 (2015).","journal-title":"Br. J. Haematol."},{"key":"34878_CR22","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/0002-9378(93)90378-V","volume":"168","author":"TC Dahlman","year":"1993","unstructured":"Dahlman, T. C. Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin. Am. J. Obstet. Gynecol. 168, 1265\u20131270 (1993).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"34878_CR23","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/0049-3848(86)90333-6","volume":"44","author":"J Harenberg","year":"1986","unstructured":"Harenberg, J., Wurzner, B., Zimmermann, R. & Schettler, G. Bioavailability and antagonization of the low molecular weight heparin CY 216 in man. Thromb. Res. 44, 549\u2013554 (1986).","journal-title":"Thromb. Res."},{"key":"34878_CR24","doi-asserted-by":"publisher","first-page":"20200137","DOI":"10.1002\/VIW.20200137","volume":"3","author":"C Li","year":"2022","unstructured":"Li, C., Wu, P., Dou, Y., Li, Q. & Zhang, J. Bioresponsive nanoplatforms for imaging and therapy of cardiovascular diseases. VIEW 3, 20200137 (2022).","journal-title":"VIEW"},{"key":"34878_CR25","doi-asserted-by":"publisher","first-page":"120200","DOI":"10.1016\/j.biomaterials.2020.120200","volume":"255","author":"Z Zhao","year":"2020","unstructured":"Zhao, Z. et al. Emerging nanotherapeutics for antithrombotic treatment. Biomaterials 255, 120200 (2020).","journal-title":"Biomaterials"},{"key":"34878_CR26","doi-asserted-by":"publisher","first-page":"eabc0382","DOI":"10.1126\/sciadv.abc0382","volume":"6","author":"X Xu","year":"2020","unstructured":"Xu, X. et al. Self-regulated hirudin delivery for anticoagulant therapy. Sci. Adv. 6, eabc0382 (2020).","journal-title":"Sci. Adv."},{"key":"34878_CR27","doi-asserted-by":"publisher","first-page":"e1905145","DOI":"10.1002\/adma.201905145","volume":"32","author":"J Xu","year":"2020","unstructured":"Xu, J. et al. Engineered nanoplatelets for targeted delivery of plasminogen activators to reverse thrombus in multiple mouse thrombosis models. Adv. Mater. 32, e1905145 (2020).","journal-title":"Adv. Mater."},{"key":"34878_CR28","doi-asserted-by":"publisher","first-page":"e2001647","DOI":"10.1002\/smll.202001647","volume":"16","author":"S Hassanpour","year":"2020","unstructured":"Hassanpour, S. et al. Thrombolytic agents: nanocarriers in controlled release. Small 16, e2001647 (2020).","journal-title":"Small"},{"key":"34878_CR29","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.3390\/ijms21061918","volume":"21","author":"C Gutmann","year":"2020","unstructured":"Gutmann, C., Siow, R., Gwozdz, A. M., Saha, P. & Smith, A. Reactive oxygen species in venous thrombosis. Int. J. Mol. Sci. 21, 1918 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"34878_CR30","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/jth.13911","volume":"16","author":"T Iba","year":"2018","unstructured":"Iba, T. & Levy, J. H. Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis. J. Thromb. Haemost. 16, 231\u2013241 (2018).","journal-title":"J. Thromb. Haemost."},{"key":"34878_CR31","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.addr.2020.09.006","volume":"160","author":"CG Figueroa-Espada","year":"2020","unstructured":"Figueroa-Espada, C. G., Hofbauer, S., Mitchell, M. J. & Riley, R. S. Exploiting the placenta for nanoparticle-mediated drug delivery during pregnancy. Adv. Drug Deliv. Rev. 160, 244\u2013261 (2020).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"34878_CR32","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1080\/17425255.2018.1397131","volume":"13","author":"YL Zhang","year":"2017","unstructured":"Zhang, Y. L. et al. Current understanding of the toxicological risk posed to the fetus following maternal exposure to nanoparticles. Expert Opin. Drug Metab. Toxicol. 13, 1251\u20131263 (2017).","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"34878_CR33","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nnano.2011.41","volume":"6","author":"K Yamashita","year":"2011","unstructured":"Yamashita, K. et al. Silica and titanium dioxide nanoparticles cause pregnancy complications in mice. Nat. Nanotechnol. 6, 321\u2013328 (2011).","journal-title":"Nat. Nanotechnol."},{"key":"34878_CR34","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.biomaterials.2016.08.010","volume":"105","author":"Q Zhang","year":"2016","unstructured":"Zhang, Q. et al. A superoxide dismutase\/catalase mimetic nanomedicine for targeted therapy of inflammatory bowel disease. Biomaterials 105, 206\u2013221 (2016).","journal-title":"Biomaterials"},{"key":"34878_CR35","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1097\/MPG.0b013e3181818e3f","volume":"47","author":"J Belkind-Gerson","year":"2008","unstructured":"Belkind-Gerson, J., Carre\u00f3n-Rodr\u00edguez, A., Contreras-Ochoa, C. O., Estrada-Mondaca, S. & Parra-Cabrera, M. S. Fatty acids and neurodevelopment. J. Pediatr. Gastroenterol. Nutr. 47, S7\u2013S9 (2008).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"34878_CR36","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3389\/fphar.2015.00206","volume":"6","author":"A Kumar","year":"2015","unstructured":"Kumar, A. & Singh, A. A review on mitochondrial restorative mechanism of antioxidants in Alzheimer\u2019s disease and other neurological conditions. Front. Pharmacol. 6, 206 (2015).","journal-title":"Front. Pharmacol."},{"key":"34878_CR37","doi-asserted-by":"publisher","first-page":"9815","DOI":"10.1073\/pnas.0903369106","volume":"106","author":"D Peters","year":"2009","unstructured":"Peters, D. et al. Targeting atherosclerosis by using modular, multifunctional micelles. Proc. Natl Acad. Sci. USA 106, 9815\u20139819 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"34878_CR38","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1073\/pnas.0610298104","volume":"104","author":"D Simberg","year":"2007","unstructured":"Simberg, D. et al. Biomimetic amplification of nanoparticle homing to tumors. Proc. Natl Acad. Sci. USA 104, 932\u2013936 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"34878_CR39","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1182\/blood-2010-03-274258","volume":"116","author":"L Agemy","year":"2010","unstructured":"Agemy, L. et al. Nanoparticle-induced vascular blockade in human prostate cancer. Blood 116, 2847\u20132856 (2010).","journal-title":"Blood"},{"key":"34878_CR40","doi-asserted-by":"publisher","first-page":"8021","DOI":"10.1016\/j.biomaterials.2011.07.014","volume":"32","author":"T Yoshitomi","year":"2011","unstructured":"Yoshitomi, T., Hirayama, A. & Nagasaki, Y. The ROS scavenging and renal protective effects of pH-responsive nitroxide radical-containing nanoparticles. Biomaterials 32, 8021\u20138028 (2011).","journal-title":"Biomaterials"},{"key":"34878_CR41","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/anie.200804135","volume":"48","author":"J Zhang","year":"2009","unstructured":"Zhang, J. & Ma, P. X. Polymeric core-shell assemblies mediated by host-guest interactions: versatile nanocarriers for drug delivery. Angew. Chem. Int. Ed. 48, 964\u2013968 (2009).","journal-title":"Angew. Chem. Int. Ed."},{"key":"34878_CR42","doi-asserted-by":"publisher","first-page":"1800781","DOI":"10.1002\/advs.201800781","volume":"5","author":"L Li","year":"2018","unstructured":"Li, L. et al. A broad-spectrum ROS-eliminating material for prevention of inflammation and drug-induced organ toxicity. Adv. Sci. 5, 1800781 (2018).","journal-title":"Adv. Sci."},{"key":"34878_CR43","first-page":"259","volume":"35","author":"M Stegnar","year":"1981","unstructured":"Stegnar, M., Accetto, B., Budihna, N. & Miklavcic, L. Relation of blood coagulation, fibrinolysis and platelet aggregation tests to development of deep vein thrombosis in high risk medical patients. Acta Med. Iugosl. 35, 259\u2013267 (1981).","journal-title":"Acta Med. Iugosl."},{"key":"34878_CR44","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1161\/01.CIR.99.25.3308","volume":"99","author":"E De Candia","year":"1999","unstructured":"De Candia, E., De Cristofaro, R. & Landolfi, R. Thrombin-induced platelet activation is inhibited by high- and low-molecular-weight heparin. Circulation 99, 3308\u20133314 (1999).","journal-title":"Circulation"},{"key":"34878_CR45","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1182\/blood-2008-02-140970","volume":"112","author":"H Yin","year":"2008","unstructured":"Yin, H. et al. Src family tyrosine kinase Lyn mediates VWF\/GPIb-IX-induced platelet activation via the cGMP signaling pathway. Blood 112, 1139\u20131146 (2008).","journal-title":"Blood"},{"key":"34878_CR46","doi-asserted-by":"publisher","first-page":"102244","DOI":"10.1016\/j.redox.2022.102244","volume":"50","author":"L Wang","year":"2022","unstructured":"Wang, L. et al. The extracellular Ero1\u03b1\/PDI electron transport system regulates platelet function by increasing glutathione reduction potential. Redox Biol. 50, 102244 (2022).","journal-title":"Redox Biol."},{"key":"34878_CR47","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.cbi.2017.05.015","volume":"272","author":"GB Santos","year":"2017","unstructured":"Santos, G. B. et al. Nitroxide 4-hydroxy-2,2\u2032,6,6\u2032-tetramethylpiperidine 1-oxyl (Tempol) inhibits the reductase activity of protein disulfide isomerase via covalent binding to the Cys400 residue on CXXC redox motif at the a\u2032active site. Chem. Biol. Interact. 272, 117\u2013124 (2017).","journal-title":"Chem. Biol. Interact."},{"key":"34878_CR48","doi-asserted-by":"publisher","first-page":"9957","DOI":"10.1021\/acsnano.6b04124","volume":"10","author":"J Cheng","year":"2016","unstructured":"Cheng, J. et al. Facile assembly of cost-effective and locally applicable or injectable nanohemostats for hemorrhage control. ACS Nano 10, 9957\u20139973 (2016).","journal-title":"ACS Nano"},{"key":"34878_CR49","doi-asserted-by":"publisher","first-page":"6615","DOI":"10.1016\/j.biomaterials.2012.06.055","volume":"33","author":"Z Yang","year":"2012","unstructured":"Yang, Z., Tu, Q., Wang, J. & Huang, N. The role of heparin binding surfaces in the direction of endothelial and smooth muscle cell fate and re-endothelialization. Biomaterials 33, 6615\u20136625 (2012).","journal-title":"Biomaterials"},{"key":"34878_CR50","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00795-019-00220-x","volume":"52","author":"S Tamaru","year":"2019","unstructured":"Tamaru, S. et al. Heparin prevents oxidative stress-induced apoptosis in human decidualized endometrial stromal cells. Med. Mol. Morphol. 52, 209\u2013216 (2019).","journal-title":"Med. Mol. Morphol."},{"key":"34878_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2010.10.064","volume":"1368","author":"LN Hao","year":"2011","unstructured":"Hao, L. N., Zhang, Q. Z., Yu, T. G., Cheng, Y. N. & Ji, S. L. Antagonistic effects of ultra-low-molecular-weight heparin on A\u03b225-35-induced apoptosis in cultured rat cortical neurons. Brain Res. 1368, 1\u201310 (2011).","journal-title":"Brain Res."},{"key":"34878_CR52","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1182\/blood-2005-05-2152","volume":"107","author":"JG Wang","year":"2006","unstructured":"Wang, J. G. et al. The principal eosinophil peroxidase product, HOSCN, is a uniquely potent phagocyte oxidant inducer of endothelial cell tissue factor activity: a potential mechanism for thrombosis in eosinophilic inflammatory states. Blood 107, 558\u2013565 (2006).","journal-title":"Blood"},{"key":"34878_CR53","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/35025220","volume":"407","author":"P Carmeliet","year":"2000","unstructured":"Carmeliet, P. & Jain, R. K. Angiogenesis in cancer and other diseases. Nature 407, 249\u2013257 (2000).","journal-title":"Nature"},{"key":"34878_CR54","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.cbi.2003.08.003","volume":"146","author":"PR Deepa","year":"2003","unstructured":"Deepa, P. R. & Varalakshmi, P. Protective effect of low molecular weight heparin on oxidative injury and cellular abnormalities in adriamycin-induced cardiac and hepatic toxicity. Chem. Biol. Interact. 146, 201\u2013210 (2003).","journal-title":"Chem. Biol. Interact."},{"key":"34878_CR55","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/S0741-5214(98)70060-6","volume":"28","author":"LJ Downing","year":"1998","unstructured":"Downing, L. J. et al. Low-dose low-molecular-weight heparin is anti-inflammatory during venous thrombosis. J. Vasc. Surg. 28, 848\u2013854 (1998).","journal-title":"J. Vasc. Surg."},{"key":"34878_CR56","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1146\/annurev-cellbio-100814-125620","volume":"31","author":"E Maltepe","year":"2015","unstructured":"Maltepe, E. & Fisher, S. J. Placenta: the forgotten organ. Annu. Rev. Cell Dev. Biol. 31, 523\u2013552 (2015).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"34878_CR57","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nature26002","volume":"555","author":"V Perez-Garcia","year":"2018","unstructured":"Perez-Garcia, V. et al. Placentation defects are highly prevalent in embryonic lethal mouse mutants. Nature 555, 463\u2013468 (2018).","journal-title":"Nature"},{"key":"34878_CR58","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nrcardio.2012.64","volume":"9","author":"F Otsuka","year":"2012","unstructured":"Otsuka, F. et al. The importance of the endothelium in atherothrombosis and coronary stenting. Nat. Rev. Cardiol. 9, 439\u2013453 (2012).","journal-title":"Nat. Rev. Cardiol."},{"key":"34878_CR59","first-page":"189168","volume":"2014","author":"ZH Wang","year":"2014","unstructured":"Wang, Z. H., Ren, W. Y., Zhu, L. & Hu, L. J. Plasminogen activator inhibitor-1 regulates LPS induced inflammation in rat macrophages through autophagy activation. Sci. World J. 2014, 189168 (2014).","journal-title":"Sci. World J."},{"key":"34878_CR60","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1161\/01.ATV.20.12.2511","volume":"20","author":"L Bajzar","year":"2000","unstructured":"Bajzar, L. Thrombin activatable fibrinolysis inhibitor and an antifibrinolytic pathway. Arterioscler. Thromb. Vasc. Biol. 20, 2511\u20132518 (2000).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"34878_CR61","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.jvsv.2014.02.004","volume":"2","author":"AT Obi","year":"2014","unstructured":"Obi, A. T. et al. Low-molecular-weight heparin modulates vein wall fibrotic response in a plasminogen activator inhibitor 1-dependent manner. J. Vasc. Surg. Venous Lymphat. Disord. 2, 441\u2013450 (2014).","journal-title":"J. Vasc. Surg. Venous Lymphat. Disord."},{"key":"34878_CR62","doi-asserted-by":"publisher","first-page":"e12520","DOI":"10.1111\/jpi.12520","volume":"65","author":"L Sagrillo-Fagundes","year":"2018","unstructured":"Sagrillo-Fagundes, L., Assuncao Salustiano, E. M., Ruano, R., Markus, R. P. & Vaillancourt, C. Melatonin modulates autophagy and inflammation protecting human placental trophoblast from hypoxia\/reoxygenation. J. Pineal Res. 65, e12520 (2018).","journal-title":"J. Pineal Res."},{"key":"34878_CR63","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1161\/CIRCULATIONAHA.114.012749","volume":"131","author":"M Blondon","year":"2015","unstructured":"Blondon, M., Quon, B. S., Harrington, L. B., Bounameaux, H. & Smith, N. L. Association between newborn birth weight and the risk of postpartum maternal venous thromboembolism: a population-based case-control study. Circulation 131, 1471\u20131476 (2015).","journal-title":"Circulation"},{"key":"34878_CR64","doi-asserted-by":"publisher","first-page":"6194","DOI":"10.1021\/acsnano.7b02308","volume":"11","author":"C Kang","year":"2017","unstructured":"Kang, C. et al. Fibrin-targeted and H2O2-responsive nanoparticles as a theranostics for thrombosed vessels. ACS Nano 11, 6194\u20136203 (2017).","journal-title":"ACS Nano"},{"key":"34878_CR65","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/rth2.12107","volume":"2","author":"F Swieringa","year":"2018","unstructured":"Swieringa, F., Spronk, H. M. H., Heemskerk, J. W. M. & van der Meijden, P. E. J. Integrating platelet and coagulation activation in fibrin clot formation. Res. Pract. Thromb. Haemost. 2, 450\u2013460 (2018).","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"34878_CR66","first-page":"65","volume":"543","author":"L Bara","year":"1988","unstructured":"Bara, L. & Samama, M. Pharmacokinetics of low molecular weight heparins. Acta Chir. Scand. 543, 65\u201372 (1988).","journal-title":"Acta Chir. Scand."},{"key":"34878_CR67","doi-asserted-by":"publisher","first-page":"3642","DOI":"10.3390\/ijms20153642","volume":"20","author":"B Zhang","year":"2019","unstructured":"Zhang, B., Liang, R., Zheng, M., Cai, L. & Fan, X. Surface-functionalized nanoparticles as efficient tools in targeted therapy of pregnancy complications. Int. J. Mol. Sci. 20, 3642 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"34878_CR68","doi-asserted-by":"publisher","DOI":"10.1007\/s40820-020-00434-0","volume":"12","author":"M Su","year":"2020","unstructured":"Su, M. et al. Nano-medicine for thrombosis: a precise diagnosis and treatment strategy. Nano-Micro Lett. 12, 96 (2020).","journal-title":"Nano-Micro Lett."},{"key":"34878_CR69","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.mattod.2017.09.003","volume":"20","author":"J Guo","year":"2017","unstructured":"Guo, J. et al. A myeloperoxidase-responsive and biodegradable luminescent material for real-time imaging of inflammatory diseases. Mater. Today 20, 493\u2013500 (2017).","journal-title":"Mater. Today"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34878-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34878-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34878-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T13:59:57Z","timestamp":1669211997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34878-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,22]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["34878"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-34878-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,22]]},"assertion":[{"value":"13 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.B.Q., J.C., S.Q.Z., and X.Y.J. are inventors in a pending patent filed by the China National Intellectual Property Administration (No. 202210798192.X, July 06 2022) related to TLH NP and CTLH NP, but the rights belong to the Women and Children\u2019s Hospital of Chongqing Medical University. All other authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7166"}}